JPMorgan Chase & Co. Raises Stock Position in National Research Co. (NASDAQ:NRC)

JPMorgan Chase & Co. increased its position in shares of National Research Co. (NASDAQ:NRC - Free Report) by 159.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 44,602 shares of the company's stock after acquiring an additional 27,408 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.19% of National Research worth $787,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. KLP Kapitalforvaltning AS acquired a new stake in shares of National Research during the fourth quarter worth $50,000. American Century Companies Inc. boosted its stake in National Research by 8.1% in the 4th quarter. American Century Companies Inc. now owns 39,254 shares of the company's stock worth $692,000 after buying an additional 2,956 shares during the last quarter. Semanteon Capital Management LP grew its holdings in National Research by 9.9% in the 4th quarter. Semanteon Capital Management LP now owns 10,281 shares of the company's stock valued at $181,000 after buying an additional 929 shares during the period. Teacher Retirement System of Texas increased its stake in shares of National Research by 23.8% during the 4th quarter. Teacher Retirement System of Texas now owns 57,826 shares of the company's stock valued at $1,020,000 after acquiring an additional 11,105 shares during the last quarter. Finally, Signaturefd LLC lifted its holdings in shares of National Research by 613.3% during the 4th quarter. Signaturefd LLC now owns 4,173 shares of the company's stock worth $74,000 after acquiring an additional 3,588 shares during the period. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Trading Up 5.5 %

National Research stock traded up $0.66 during trading on Friday, reaching $12.77. The company had a trading volume of 97,269 shares, compared to its average volume of 95,056. National Research Co. has a 12-month low of $9.76 and a 12-month high of $35.81. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The stock's 50 day moving average price is $12.91 and its two-hundred day moving average price is $16.28. The firm has a market capitalization of $293.02 million, a price-to-earnings ratio of 12.16 and a beta of 0.34.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $0.25 earnings per share (EPS) for the quarter. The company had revenue of $33.55 million during the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.76%. National Research's dividend payout ratio (DPR) is 46.60%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.